September 16, 2019 - Prostate Cancer Canada today announced a $2 million investment in prostate cancer research, awarding 10 projects Prostate Cancer Canada and Movember 2019 Discovery Grants. Grant recipients include the Vancouver Prostate Centre's Drs Cox, Gleave and Goldenberg.
Each year, the UBC Faculty of Medicine recognizes faculty and staff members for excellence in teaching, research, administration, innovation and public service. This year, UBC Faculty of Medicine Distinguished Achievement Awards were given to Dr. Alexander Wyatt (Excellence in Basic Science Research) and Dr. Poul Sorensen (Overall Excellence – Senior Faculty).
The Vancouver Prostate Centre has recently acquired and commissioned a state-of-the-art high resolution (29 MHz) micro-ultrasound machine —called the ExactVu micro-ultrasound -- for use in image-guided targeted biopsies of the prostate. This technology, which is now part of our regular clinical workflow, enables our urologists to accurately identify and biopsy cancer lesions in the prostate, and can also be used as an aid in delivering targeted focal therapies to the tumour.
Dr. Ryan Flannigan and his colleagues are studying a new treatment for men suffering from chronic scrotal pain.
The TITAN clinical trial has demonstrated that the addition of apalutamide to androgen-deprivation therapy significantly improved radiographic progression-free survival and overall survival in patients with metastatic castration-sensitive prostate cancer. These results were presented by Dr. Kim Chi at ASCO on May 31, and were written up on ASCO Daily News on June 1. Dr.
May 4, 2019 - Dr. Martin Gleave gave the AUA 2019's Ramon Guiteras Lecture, a plenary invited lecture named after the AUA's founder. Click here to read the original story at AUA Daily News, the text of which is copied below.
St. Baldrick’s Foundation Awards One-of-a-Kind Grant to Aid in Childhood Cancer Research Discovery: St. Baldrick’s Robert J. Arceci Innovation Award provides scientists opportunity to pursue unrestricted research
April 17, 2019 - Dr. Sriram Subramaniam has joined the University of British Columbia (UBC) as the Gobind Khorana Canada Excellence Research Chair in Precision Cancer Drug Design.
Dr. Subramaniam is recognized as a global leader in the emerging field of cryo-electron microscopy, or cryo-EM, a technology that has sparked a revolution in imaging of protein complexes. He is appointed both in the Department of Urologic Sciences and in Biochemistry and Molecular biology at UBC and is linked to the precision cancer drug design program at the Vancouver Prostate Centre.